Gerald McLaughlin

Chief Executive Officer & Director at Neos Therapeutics, Inc.

Gerald McLaughlin

Gerald McLaughlin

Chief Executive Officer & Director at Neos Therapeutics, Inc.

Overview
Career Highlights

Neos Therapeutics, Inc.
AgeneBio, Inc.

RelSci Relationships

2356

Number of Boards

3

Birthday

1968

Age

52

Relationships
RelSci Relationships are individuals Gerald McLaughlin likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at AgeneBio, Inc.

Relationship likelihood: Strong

Co-Founder at Emerald Bioscience, Inc.

Relationship likelihood: Strong

Former Chief Executive Officer, Director & MD at Emerald Bioscience, Inc.

Relationship likelihood: Strong

Former Director & Executive Vice President-Corporate Development at Performance Health Technologies, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Sarepta Therapeutics, Inc.

Relationship likelihood: Strong

Former Chief Financial Officer & Chief Accounting Officer at Deckers Outdoor Corp.

Relationship likelihood: Strong

Former Director, Global Marketing Oncology at Amgen, Inc.

Relationship likelihood: Strong

Operating Partner at Water Street Healthcare Partners LLC

Relationship likelihood: Strong

Treasurer & Chief Financial Officer at Neos Therapeutics, Inc.

Relationship likelihood: Strong

Senior Vice President, General Counsel & Corporate Secretary at Neos Therapeutics, Inc.

Relationship likelihood: Strong

Paths to Gerald McLaughlin
Potential Connections via
Relationship Science
You
Gerald McLaughlin
Chief Executive Officer & Director at Neos Therapeutics, Inc.
Career History
Chief Executive Officer & Director
2018 - Current

Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX.

Senior Director-Strategic Marketing
2001 - Prior

Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA.

President & Chief Executive Officer
2014 - 2018

AgeneBio, Inc. develops an innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function. It research focused on cognitive neuroscience and the neurobiology of the aging brain with most advanced clinical program targets amnestic mild cognitive impairment (aMCI), the symptomatic, pre-dementia stage of Alzheimer’s. The company was founded by Michela Gallagher in 2008 and is headquartered in Baltimore, MD.

Transactions
Details Hidden

AgeneBio, Inc. raised money in a private placement transaction

Details Hidden

AgeneBio, Inc. raised money in a private placement transaction

Details Hidden

AgeneBio, Inc. raised money in a private placement transaction

Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Gerald McLaughlin. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Gerald McLaughlin's profile does not indicate a business or promotional relationship of any kind between RelSci and Gerald McLaughlin.